2026 Best of Hematology: Chronic Leukemia: Targetable Pathways in CLL - Dr Steven Bair
In this session, Dr Steven Bair discusses targeted treatment pathways in chronic myeloid leukemia.
▶︎
Modern Targeted Treatment Strategies in CLL
▶︎
2026 Best of Hematology: Myelodysplastic and Myeloproliferative Neoplasms - Dr Samuel Urrutia
▶︎
Your Multiple Myeloma Lab Results, Decoded: What They Mean and What They Don’t
▶︎
Improving Transdermal Fentanyl Prescribing
▶︎
Ronald Hoffman, MD - Drivers of Progression of MPNs
▶︎
NestJS Full Course for Beginners in 2026 | Build a Production-Ready API
▶︎
How AI Cracked the Protein Folding Code and Won a Nobel Prize
▶︎
Lymphoma
▶︎
Provider Connections Dr Sameer Parikh on Updates to Frontline Therapy of CLL Watch and Wait
▶︎
JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma
▶︎
2026 CLL Update: Game Changer Therapies for Oncologists?
▶︎
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎
Use These 5 Food Hacks To Heal The Body & STARVE CANCER I Dr. William Li
▶︎
But what is quantum computing? (Grover's Algorithm)
▶︎
2026 Best of Hematology: Moving Beyond R-CHOP in DLBCL - Dr Michael Tees
▶︎
CAOH 2025: Ana C Garrido Castro, MD - Assistant Professor of Medicine, Dana Farber Cancer Institute
▶︎
Understanding Mantle Cell Lymphoma: From Diagnosis to Treatment
▶︎
Chronic Cancer Tests: Chronic Lymphocytic Leukemia | The Patient Story
▶︎
2026 Best of Hematology: What's New in the T-Cell and Rare Lymphomas? - Dr Bradley Haverkos,
▶︎